Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Smith Martin Alexander. Director active across 1 company, notably Idexx Laboratories INC /de. Cumulatively, 8 disclosures have been published. History available since 1 September 2022. The latest transaction was disclosed on 14 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Smith Martin Alexander is a declarant linked to Idexx Laboratories INC /de, where he is Executive Vice President. He has filed 8 disclosures in total, and the sampled recent filings cover the period from 2022-09-06 to 2026-02-17. The total buy amount is EUR 0 and the total sell amount is EUR 0 across these recent filings, with the most frequent transaction nature indicated as option exercise.